Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medicina (Kaunas, Lithuania)|February 26, 2025
Prolonged Corticosteroid Use in the Treatment of Tuberculous Meningoencephalitis: A Case ReportAnnija Holstroma, Arturs Balodis, Artis Brokans, et al.
Pharmacogenomics and Personalized Medicine|November 17, 2022
Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length <i>CYP2E1</i> Gene Polymorphism AnalysisViktorija Igumnova, Agnija Kivrane, Anda Viksna, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 19, 2024
Endogenous reactivation cases identified by whole genome sequencing of <i>Mycobacterium tuberculosis</i>: Exploration of possible causes in Latvian tuberculosis patientsAnda Viksna, Darja Sadovska, Vija Riekstina, et al.
Pharmacogenomics|May 18, 2021
Implementation of a next-generation sequencing-based targeted approach for full-length <i>CYP3A4</i> gene sequencingAgnija Kivrane, Viktorija Igumnova, Janis Kimsis, et al.
Pharmaceutics|March 28, 2024
Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic PerspectiveAgnija Kivrane, Viktorija Ulanova, Solveiga Grinberga, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 23, 2021
LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoringAgnija Kivrane, Solveiga Grinberga, Eduards Sevostjanovs, et al.
Antibiotics (Basel, Switzerland)|January 8, 2025
Identification of Factors Determining Patterns of Serum C-Reactive Protein Level Reduction in Response to Treatment Initiation in Patients with Drug-Susceptible Pulmonary TuberculosisAgnija Kivrane, Viktorija Ulanova, Solveiga Grinberga, et al.
Frontiers in Pharmacology|April 8, 2024
Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationshipsViktorija Ulanova, Agnija Kivrane, Anda Viksna, et al.
Pageof 1